Reference : Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification... |
Scientific journals : Article | |||
Human health sciences : Rheumatology | |||
http://hdl.handle.net/2268/72446 | |||
Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt | |
French | |
[en] Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest | |
De Seny, Dominique [Université de Liège - ULiège > > Rhumatologie >] | |
Ribbens, Clio [Université de Liège - ULiège > > Rhumatologie >] | |
Cobraiville, Gaël [Université de Liège - ULiège > > Rhumatologie - Chimie médicale >] | |
Meuwis, Marie-Alice [Université de Liège - ULiège > > GIGA-Management : Plate-forme protéomique >] | |
Marée, Raphaël [Université de Liège - ULiège > > GIGA-Management : Plateforme bioinformatique >] | |
Geurts, Pierre [Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Systèmes et modélisation >] | |
Wehenkel, Louis [Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Systèmes et modélisation >] | |
Louis, Edouard ![]() | |
Merville, Marie-Paule [Université de Liège - ULiège > Département de pharmacie > Chimie médicale >] | |
Fillet, Marianne [Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments >] | |
Malaise, Michel [Université de Liège - ULiège > Département des sciences cliniques > Rhumatologie >] | |
2009 | |
Revue Médicale de Liège | |
Hopital de Baviere | |
64 | |
Spec No | |
29-35 | |
Yes (verified by ORBi) | |
National | |
0370-629X | |
2566-1566 | |
Liège | |
Belgique | |
[en] proteomics ; biomarkers ; SELDI-TOF-MS | |
[en] Clinical proteomics is a technical approach studying the entire proteome
expressed by cells, tissues or organs. It describes the dynamics of cell regulation by detecting molecular events related to diseases development. Proteomic techniques focus mainly on identification of new biomarkers or new therapeutic targets. It is a multidisciplinary approach using medical, biological, bioanalytical and bioinformatics knowledges. A strong collaboration between these fields allowed SELDI-TOF-MS proteomics studies to be performed at the CHU and the University of Liege, in GIGA-Research facilities. The aim of these studies was driven along three main axes of research related to the identification of biomarkers specific to a studied pathology, to a common biological pathway and, finally, to a treatment response. | |
Researchers ; Professionals ; Students ; General public | |
http://hdl.handle.net/2268/72446 | |
http://www.rmlg.ulg.ac.be | |
This work was presented in the setting of the "Synthese CHU 2009" meeting. |
File(s) associated to this reference | ||||||||||||||
Fulltext file(s):
| ||||||||||||||
All documents in ORBi are protected by a user license.